Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo Hu

Showing results (371-380 of 372) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 372 results.
Plos One|December 22, 2025
Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical modelsYusuke Tomita, Gabrielle Link, Yi Ge, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cellsHai-Tong Fang, Bo Zhang, Xiao-Fen Pan, et al.
Pageof 38

Showing results (371-380 of 372) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 372 results.
Plos One|December 22, 2025
Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical modelsYusuke Tomita, Gabrielle Link, Yi Ge, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cellsHai-Tong Fang, Bo Zhang, Xiao-Fen Pan, et al.
Pageof 38